Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.1.1.363 extracted from

  • Schmidt, R.; De Jager, V.; Zuehlke, D.; Wolff, C.; Bernhardt, J.; Cankar, K.; Beekwilder, J.; Van Ijcken, W.; Sleutels, F.; De Boer, W.; Riedel, K.; Garbeva, P.
    Fungal volatile compounds induce production of the secondary metabolite sodorifen in Serratia plymuthica PRI-2C (2017), Sci. Rep., 7, 862 .
    View publication on PubMedView publication on EuropePMC

Cloned(Commentary)

Cloned (Comment) Organism
expression in Escherichia coli Serratia plymuthica

Organism

Organism UniProt Comment Textmining
Serratia plymuthica A0A1B1KQN4
-
-
Serratia plymuthica PRI-2C A0A1B1KQN4
-
-

Synonyms

Synonyms Comment Organism
demethylrebeccamycin-D-glucose O-methyltransferase
-
Serratia plymuthica
Q5A_011540
-
Serratia plymuthica
SpMT
-
Serratia plymuthica

General Information

General Information Comment Organism
physiological function Serratia plymuthica responds to fungal volatile organic compounds with changes in gene and protein expression related to motility, signal transduction, energy metabolism, cell envelope biogenesis, and secondary metabolite production. The unusual terpene sodorifen is produced in response to fungal volatile organic compounds. Upon coexpression of genes encoding synthase Q5A_011535 and methyltransferase Q5A_011540, formation of sodorifen is detected in Escherichia coli cultures overproducing farnesyl diphosphate Serratia plymuthica